Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Rh Blood Group01:19

Rh Blood Group

2.7K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.7K
Blood Transfusion01:15

Blood Transfusion

2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Blood Typing01:10

Blood Typing

2.3K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Breast cancer research and treatment·2025
Same author

Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Editorial: Revisiting seed and soil: A new approach to target hibernating dormant tumor cells.

Frontiers in oncology·2023
Same author

Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.

Breast cancer research and treatment·2021
Same author

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.

Nature communications·2021
Same author

Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.

Breast cancer research and treatment·2021
Same journal

Escaping the trap.

Nature reviews. Cancer·2026
Same journal

A genomic and epigenomic lens into the biology of acute lymphoblastic leukaemia.

Nature reviews. Cancer·2026
Same journal

Systemic health impact of cancer-associated extracellular vesicles and particles.

Nature reviews. Cancer·2026
Same journal

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same journal

CLIM-TIME links tumour genetics to spatial immune architecture.

Nature reviews. Cancer·2026
Same journal

Serving sulfur to boost anti-tumour immunity.

Nature reviews. Cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Disorders of Erythrocytes
01:27

Disorders of Erythrocytes

2.0K

Does tumour dormancy offer a therapeutic target?

Paul E Goss1, Ann F Chambers

  • 1Harvard Medical School, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Lawrence House, RH-302, Boston, Massachusetts 02114, USA.

Nature Reviews. Cancer
|November 5, 2010
PubMed
Summary
This summary is machine-generated.

Cancer survivors are increasing, but tumor dormancy can cause relapse. Understanding dormant cancer cell biology is key to developing effective treatments and minimizing recurrence risk in long-term survivors.

More Related Videos

Immune Compatible Blood Transfusion and Agglutination
02:45

Immune Compatible Blood Transfusion and Agglutination

14.0K
Rh Blood Group
01:19

Rh Blood Group

2.7K

Related Experiment Videos

Last Updated: Jan 11, 2026

Disorders of Erythrocytes
01:27

Disorders of Erythrocytes

2.0K
Immune Compatible Blood Transfusion and Agglutination
02:45

Immune Compatible Blood Transfusion and Agglutination

14.0K
Rh Blood Group
01:19

Rh Blood Group

2.7K

Area of Science:

  • Oncology
  • Cancer Biology

Background:

  • The growing population of cancer survivors presents a significant clinical challenge.
  • Tumor dormancy is a major cause of cancer recurrence in long-term survivors.

Purpose of the Study:

  • To explore the biology of dormant cancer cells.
  • To identify effective treatment strategies for dormant tumors.
  • To reduce cancer recurrence in long-term cancer survivors.

Main Methods:

  • Review of preclinical cancer models.
  • Analysis of initial clinical trial data.
  • Focus on breast cancer patient examples.

Main Results:

  • Advancements in understanding tumor dormancy biology.
  • Emerging treatment approaches for dormant cancer cells.
  • Evidence from preclinical and clinical studies.

Conclusions:

  • Understanding tumor dormancy is crucial for managing cancer survivors.
  • Targeting dormant cancer cells can minimize the risk of relapse.
  • Further research and clinical trials are needed to optimize treatment strategies.